UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities

Journal of antimicrobial chemotherapy, 2016-12, Vol.71 (12), p.3575-3584

2016

Volltextzugriff (PDF)

Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2065-2075

2014

Volltextzugriff (PDF)

Analysis of Potential β-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae

Journal of clinical microbiology, 2018-04, Vol.56 (4)

2018

Volltextzugriff (PDF)

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials

Journal of antimicrobial chemotherapy, 2016-04, Vol.71 (4), p.862-870

2016

Volltextzugriff (PDF)

In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme

Journal of antimicrobial chemotherapy, 2016-01, Vol.71 (1), p.162-169

2016

Volltextzugriff (PDF)

In Vitro Activity of Ceftaroline against Bacterial Pathogens Isolated from Patients with Skin and Soft Tissue and Respiratory Tract Infections in African and Middle Eastern Countries: AWARE Global Surveillance Program 2012-2014

Diagnostic microbiology and infectious disease, 2016-10, Vol.86 (2), p.194-199

2016

Volltextzugriff (PDF)

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials

Journal of antimicrobial chemotherapy, 2016-06, Vol.71 (6), p.1748-1749

2016

Volltextzugriff (PDF)

New Antimicrobial Agents... but No Susceptibility Tests

Clinical infectious diseases, 2016-12, Vol.63 (11), p.1530-1531

2016

Volltextzugriff (PDF)

Comparison of Antibacterial Activities of Meropenem and Six Other Antimicrobials Against Pseudomonas aeruginosa Isolates from North American Studies and Clinical Trials

Clinical infectious diseases, 1997-02, Vol.24 (Supplement-2), p.S191-S196

1997

Volltextzugriff (PDF)

Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis

The Pediatric infectious disease journal, 2001-01, Vol.20 (1), p.19-24

2001

Volltextzugriff (PDF)

Potential Factors Influencing Carbapenem Activity Against Bacteroides fragilis Group Isolates

Clinical Infectious Diseases, 1995-06, Vol.20 (Supplement-2), p.S361-S363

1995

Volltextzugriff (PDF)

Are all carbapenems created equal?

Journal of antimicrobial chemotherapy, 1994-09, Vol.34 (3), p.443-444

1994

Volltextzugriff (PDF)

Clostridium difficile - associated intestinal disease in infant and adult hamsters

Iaconis, Joseph P

1988

Volltextzugriff (PDF)

Clostridium difficile-associated ileocecitis in clindamycin-treated infant hamsters

Current microbiology, 1986-11, Vol.13 (6), p.327-332

1986

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(13)
Dissertationen
(1)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities

Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective

Analysis of Potential β-Lactam Surrogates To Predict In Vitro Susceptibility and Resistance to Ceftaroline for Clinical Isolates of Enterobacteriaceae

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials

In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme

In Vitro Activity of Ceftaroline against Bacterial Pathogens Isolated from Patients with Skin and Soft Tissue and Respiratory Tract Infections in African and Middle Eastern Countries: AWARE Global Surveillance Program 2012-2014

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials

New Antimicrobial Agents... but No Susceptibility Tests

Comparison of Antibacterial Activities of Meropenem and Six Other Antimicrobials Against Pseudomonas aeruginosa Isolates from North American Studies and Clinical Trials

Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis

Potential Factors Influencing Carbapenem Activity Against Bacteroides fragilis Group Isolates

Are all carbapenems created equal?

Clostridium difficile - associated intestinal disease in infant and adult hamsters

Clostridium difficile-associated ileocecitis in clindamycin-treated infant hamsters

Suchergebnisse filtern